Anest. intenziv. Med. 2022;33(1):59 | DOI: 10.36290/aim.2022.009

Answer of authorsCorrespondence

Pavel Suk

Published: February 25, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Suk P. Answer of authors. Anest. intenziv. Med. 2022;33(1):59. doi: 10.36290/aim.2022.009.
Download citation

References

  1. Benes J, Skulec R, Jobanek J, Cerny V. Fixed-dose enoxaparin provides efficient DVT prophylaxis in mixed ICU patients despite low anti-Xa levels: A prospective observational cohort study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 May 27. doi: 10.5507/bp.2021.031. Epub ahead of print. PMID: 34042098. Go to original source... Go to PubMed...
  2. Vahtera A, Vaara S, Pettilä V, Kuitunen A. Plasma anti-FXa level as a surrogate marker of the adequacy of thromboprophylaxis in critically ill patients: A systematic review. Thromb Res. 2016 Mar;139:10-6. doi: 10.1016/j.thromres.2015.12.016. Epub 2016 Jan 4. PMID: 26916290. Go to original source... Go to PubMed...
  3. Kaplan D, Casper TC, Elliott CG, Men S, Pendleton RC, Kraiss LW, et al. VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock. Chest. 2015Nov;148(5):1224-1230. doi: 10.1378/chest.15-0287. PMID: 26111103; PMCID: PMC4631038. Go to original source... Go to PubMed...
  4. Lauzier F, Arnold DM, Rabbat C, Heels-Ansdell D, Zarychanski R, Dodek P, et al. Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis. Intensive Care Med. 2013 Dec;39(12):2135-43. doi: 10.1007/s00134-013-3044-3. Epub 2013 Aug 14. PMID: 23942857. Go to original source... Go to PubMed...
  5. Walkey AJ, Quinn EK, Winter MR, McManus DD, Benjamin EJ. Practice Patterns and Outcomes Associated With Use of Anticoagulation Among Patients With Atrial Fibrillation During Sepsis. JAMA Cardiol. 2016 Sep 1;1(6):682-90. doi: 10.1001/jamacardio.2016.2181. PMID: 27487456; PMCID: PMC5810586. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.